Drug Type Small molecule drug |
Synonyms EVEGYN |
Target |
Mechanism DNA binders(DNA binders), Ergosterol biosynthesis inhibitors, SCNA modulators(Sodium channel alpha subunit modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H21Cl2N3O4S |
InChIKeyFJNRUWDGCVDXLU-UHFFFAOYSA-N |
CAS Registry73151-29-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bacterial Vaginosis | Phase 3 | TR | 28 Sep 2023 | |
Candidiasis, Vulvovaginal | Phase 3 | TR | 28 Sep 2023 | |
Infective vaginitis | Phase 3 | TR | 28 Sep 2023 | |
Trichomonas Vaginitis | Phase 3 | TR | 28 Sep 2023 |